• Japanese
  • Korean
  • Chinese
Cover Image

U.S. Markets for Oncology-Related Diagnostic Ultrasound, Minimally Biopsy, and Tissue Screening Products

Cancer is the second-leading cause of death in the United States (U.S.) after heart disease. It is estimated that nearly 1.7 million people in the country will be diagnosed with cancer in 2014, and that approximately 585,720 will die from the disease. In the fight against cancer, diagnostic ultrasound imaging, minimally invasive biopsy, and tissue screening are among the methods that allow physicians to detect malignancies at their earliest and most treatable stages.

In 2012, approximately 92.0 million oncology-related diagnostic ultrasound, minimally invasive biopsy, and tissue screening procedures were performed in the U.S. Together, these procedures generated approximately $1.1 billion in corresponding product sales; it is expected that during the forecast period covered by this report, sales of diagnostic ultrasound, minimally invasive biopsy, and tissue screening products for oncology-related indications will increase at a compound annual rate of 3.9%, reaching nearly $1.4 billion in the year 2017.

This dynamic, new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. diagnostic ultrasound, minimally invasive biopsy, and tissue screening products arena.

Covered topics in this report include an overview of cancer in the U.S. including discussions of the different forms of the disease; automated and semi-automated tissue screening technologies; capacitive micromachined ultrasonic transducers; contrast-enhanced ultrasound; core needle biopsy systems; diagnostic ultrasound systems; Doppler and tissue harmonic imaging; fine-needle aspiration; human papilloma virus testing systems; minimally invasive biopsy; Papanicolaou smear testing systems; photoacoustic imaging; risk factors for cancer development; statistics covering new cancer cases, cancer prevalence, and cancer-related deaths; tissue elastography; and vacuum-assisted biopsy systems; among others

Table of Contents

EXECUTIVE SUMMARY

  • i. New Cancer Cases, Cancer Prevalence, and Deaths Due to Cancer
  • ii. Oncology-Related Diagnostic Ultrasound, Minimally Invasive Biopsy, and Tissue Screening Procedures
  • iii. Oncology-Related Diagnostic Ultrasound, Minimally Invasive Biopsy, and Tissue Screening Products
  • iv. Methodology

1. CANCER STATISTICS UPDATE

  • 1.1. Acquired Capabilities of Cancer Cells
  • 1.2. Cataloging Genomic Alterations Involved in the Development of Cancer
  • 1.3. Risk Factors Associated with the Development of Cancer
  • 1.4. Cancer Staging
  • 1.5. New Cancer Cases, Cancer Prevalence, and Deaths Due to Cancer
  • 1.6. Clinical and Statistical Data for Selected Types of Cancer

2. U.S. MARKETS FOR ONCOLOGY-RELATED DIAGNOSTIC ULTRASOUND, MINIMALLY INVASIVE BIOPSY, AND TISSUE SCREENING PRODUCTS

  • 2.1. Diagnostic Ultrasound Systems, Market Analysis
  • 2.2. Minimally Invasive Biopsy Systems, Market Analysis
  • 2.3. Tissue Screening, Market Analysis

3. COMPANY PROFILES

  • 3.1. Analogic Corporation
  • 3.2. Bard Biopsy Systems/ Bard Peripheral Vascular, Inc./ C.R. Bard, Inc
  • 3.3. Becton, Dickinson and Company
  • 3.4. CareFusion Corporation
  • 3.5. Fujifilm SonoSite, Inc./Fujifilm Medical Systems USA, Inc./ Fujifilm Holdings America Corporation/Fujifilm
  • 3.6. GE Healthcare, Inc./General Electric Company
  • 3.7. Hitachi Aloka Medical America/Hitachi Aloka Medical/ Hitachi Medical/Hitachi
  • 3.8. Hologic, Inc.
  • 3.9. Mammotome/Devicor Medical Products, Inc.
  • 3.10. Mindray Medical USA Corporation/Mindray Medical International LTD
  • 3.11. Philips Healthcare, Inc./Royal Philips NV
  • 3.12. Qiagen NV
  • 3.13. Samsung Medison/Samsung Electronics America, Inc./ Samsung Electronics Co., LTD/Samsung
  • 3.14. Siemens Healthcare/Siemens Medical Solutions USA, Inc./Siemens AG
  • 3.15. Toshiba America Medical Systems, Inc./Toshiba Corporation

APPENDIX: COMPANY LISTING

Note: The Table of Contents has Been Edited for Brevity. For a Completed Version, Please Request a Free Sample.

Show More
RELATED REPORTS
* Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018
  • Published:
  • Jun 17, 2014
  • USD 4650
  • 299 Pages

* MediPoint: Companion Diagnostic Tests in Oncology - Current and Future Players
  • Published:
  • May 26, 2014
  • USD 3500
  • 281 Pages

* MediPoint: Companion Diagnostic Tests in Oncology - APAC Analysis and Market Forecasts
  • Published:
  • May 21, 2014
  • USD 4450
  • 446 Pages

* MediPoint: Companion Diagnostic Tests in Oncology - EU Analysis and Market Forecasts
  • Published:
  • May 21, 2014
  • USD 4450
  • 489 Pages

* MediPoint: Companion Diagnostic Tests in Oncology - South America Analysis and Market Forecasts
  • Published:
  • May 21, 2014
  • USD 4450
  • 408 Pages

* MediPoint: Companion Diagnostic Tests in Oncology - US Analysis and Market Forecasts
  • Published:
  • May 21, 2014
  • USD 4450
  • 423 Pages

* MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts
  • Published:
  • May 05, 2014
  • USD 6495
  • 592 Pages

* Molecular Diagnostics Market (PCR, Next Generation Sequencing, Microarray, Infectious diseases, Genetic disease, Oncology testing, Blood donor screening) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
  • Published:
  • Feb 06, 2014
  • USD 4795
  • 122 Pages

* Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019
  • Published:
  • Jan 08, 2014
  • USD 4795
  • 81 Pages

* European Injectable Drug Delivery Market By Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Forecasts to 2017
  • Published:
  • Jul 05, 2013
  • USD 4650
  • 333 Pages

Browse more Ultra Sound Market Research Reports

Pricing
Get Notified
Email me when related reports are published